How effectively do we apply first-line treatment in overactive bladder?
- PMID: 35779110
- DOI: 10.1007/s00192-022-05279-2
How effectively do we apply first-line treatment in overactive bladder?
Abstract
Introduction and hypothesis: We aimed to reveal the effectiveness of the combination of behavioral therapy (BT), drug therapy, and pelvic floor muscle training (PFMT) in patients with the diagnosis of overactive bladder (OAB) who did not respond to drug therapy.
Methods: Seventy female patients aged between 18 and 65 years diagnosed with wet-type OAB, who did not respond to drug therapy, were included in our study, which was planned as a prospective randomized controlled trial. The patients were randomly assigned to one of two groups. BT and a combination of anticholinergic + beta3-agonist was implemented in the control group for 12 weeks. BT and PFMT were applied with a combination of anticholinergic + beta3-agonist in the active therapy group for 12 weeks. Post-treatment changes in OAB, ICIQ-SF scores, and frequency and nocturia were compared.
Results: The age and BMI averages of the groups were similar (p>0.01). After the treatment, no significant decrease was observed in OAB scores in the control group (p = 0.06), but a significant decrease was observed in the active therapy group (p<0.01). The mean ICIQ-SF scores and the number of nocturia were found to decrease in both groups after 12 weeks of treatment (p<0.01). There was no significant decrease in frequency in the control group (p = 0.054). It regressed significantly in the active therapy group (p<0.01). After the treatment, 3 of 30 the patients in control group (10%) and 11 of the 32 patients in the active therapy group (34.3%) said that their complaints had regressed and that they were pleased with their current situation. Although after the treatment, 4 patients in the control group were dry (13.3%), 10 patients in the active therapy group were dry (31.25%).
Conclusions: We demonstrated that drug therapy, BT, and PFMT, which are recommended in the first-line treatment of OAB reduce the need for invasive treatments when they are well explained to the patients and combined.
Keywords: Behavior therapy; Overactive; Pelvic floor; Urinary bladder.
© 2022. The International Urogynecological Association.
Similar articles
-
Bladder training compared to bladder training associated with pelvic floor muscle training for overactive bladder symptoms in women: A randomized clinical trial.Neurourol Urodyn. 2023 Nov;42(8):1802-1811. doi: 10.1002/nau.25285. Epub 2023 Sep 18. Neurourol Urodyn. 2023. PMID: 37723948 Clinical Trial.
-
Outcomes of different protocols of pelvic floor physical therapy and anti-cholinergics in women with wet over-active bladder: A 4-year follow-up.Neurourol Urodyn. 2017 Mar;36(3):755-758. doi: 10.1002/nau.23016. Epub 2016 Apr 15. Neurourol Urodyn. 2017. PMID: 27080326
-
Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials.Arch Ital Urol Androl. 2022 Dec 28;94(4):492-506. doi: 10.4081/aiua.2022.4.492. Arch Ital Urol Androl. 2022. PMID: 36576454
-
Effects of Pelvic Floor Muscle Training on Sexual Dysfunction, Sexual Satisfaction of Partners, Urinary Symptoms, and Pelvic Floor Muscle Strength in Women With Overactive Bladder: A Randomized Controlled Study.J Sex Med. 2022 Sep;19(9):1421-1430. doi: 10.1016/j.jsxm.2022.07.003. Epub 2022 Aug 5. J Sex Med. 2022. PMID: 35934663 Clinical Trial.
-
Combination therapy in overactive bladder-untapped research opportunities: A systematic review of the literature.Neurourol Urodyn. 2019 Nov;38(8):2083-2092. doi: 10.1002/nau.24158. Epub 2019 Sep 4. Neurourol Urodyn. 2019. PMID: 31483070
Cited by
-
Overactive bladder medication - do we need to revisit trospium chloride for our elderly patients?Int Urogynecol J. 2023 May;34(5):961-962. doi: 10.1007/s00192-023-05559-5. Epub 2023 Apr 26. Int Urogynecol J. 2023. PMID: 37099160 No abstract available.
References
-
- Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108:1132–8. - DOI
-
- Zumrutbas AE, Bozkurt AI, Tas E, Acar CI, Alkis O, et al. Prevalence of lower urinary tract symptoms, overactive bladder and urinary incontinence in western Turkey: results of a population-based survey. Int J Urol. 2014;21(10):1027–33. - DOI
-
- Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrebroeck P, et al. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn. 2009;28(4):287. https://doi.org/10.1002/nau.20737 . - DOI - PubMed
-
- Wein AJ, Kavoussi LR, Partin AV, Peters CA. Campbell-Walsh urology, 11th edition. Elsevier, Amsterdam; 2016.
-
- Smith A, Bevan D, Douglas HR, James D. Management of urinary incontinence in women: summary of updated NICE guidance. BMJ. 2013;347:f5170. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical